Intellia Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
50%
€38.49
Target price
31.03.26
€50.00
Performance (%)
-68.33%
End price
14.12.24
€12.19
Summary
This prediction ended on 14.12.24 with a price of €12.19. The BUY prediction by BiotechBee for Intellia Therapeutics Inc performed very badly with a performance of -68.33%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 8.566% | 8.566% | 19.934% |
| iShares Core DAX® | -0,38 % | 2,61 % | 11,34 % |
| iShares Nasdaq 100 | -0,41 % | -2,00 % | 5,35 % |
| iShares Nikkei 225® | 1,84 % | 9,39 % | 33,53 % |
| iShares S&P 500 | -0,71 % | -0,48 % | 2,51 % |
According to BiotechBee what are the pros and cons of Intellia Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Buy mit Kursziel 50,0